To include your compound in the COVID-19 Resource Center, submit it here.

Cerestat: Began a placebo-controlled safety trial using fixed doses instead of doses based on patients' weight, to run concomitantly with an on-going Phase II d

Cambridge Neuroscience Inc. (CNSI), Cambridge,

Read the full 57 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE